Description
Chymotrypsin Solution for Injections 0.01g. №10 Vial
Ingredients:
Each vial contains Chymotrypsin 0.01g as the active ingredient.
Mechanism of Action:
Chymotrypsin exerts its pharmacological effects by enzymatically breaking down proteins, leading to the reduction of inflammation and swelling in the affected area. This proteolytic enzyme acts by specifically targeting peptide bonds.
Pharmacological Properties:
Chymotrypsin demonstrates anti-inflammatory and anti-edematous properties through its selective cleavage of peptide bonds at aromatic or large hydrophobic amino acids, contributing to the resolution of inflammation and edema.
Indications for Use:
Chymotrypsin solution is indicated for managing inflammation and swelling associated with specific eye conditions, including postoperative inflammation and traumatic edema, providing therapeutic benefits in these clinical scenarios.
Contraindications:
Avoid the use of Chymotrypsin solution if there is a known hypersensitivity to Chymotrypsin or any other components of the formulation. Prior consultation with a healthcare provider is essential before use in individuals who are pregnant, lactating, or have a history of allergic reactions to enzyme preparations.
Side Effects:
Adverse effects associated with Chymotrypsin solution may encompass local reactions at the injection site, such as erythema, swelling, or discomfort. In rare instances, allergic manifestations or hypersensitivity reactions may manifest. Prompt medical attention is warranted if any untoward effects are experienced.
Usage Instructions:
Dosage: The dosing regimen of Chymotrypsin solution should be tailored to individual patient requirements based on disease severity and treatment response. Administration is typically performed by healthcare professionals via injection at the site of pathology. Self-administration without medical oversight should be avoided.
Benefits Compared to Analogues:
Chymotrypsin solution presents a targeted therapeutic approach in alleviating inflammation and edema, offering localized relief with minimal systemic effects in contrast to corticosteroids or non-steroidal anti-inflammatory drugs commonly employed in analogous conditions.
Suitable Patient Groups:
While generally deemed safe for adult patients, caution should be exercised when considering the use of Chymotrypsin solution in pediatric populations, geriatric individuals, and patients with known sensitivities to enzyme products. Consultation with a healthcare provider is advised for personalized treatment recommendations.
Storage and Shelf Life:
Chymotrypsin solution should be stored according to the manufacturer’s guidelines, typically at controlled room temperature shielded from light and moisture. Adherence to specific storage instructions on the product label is imperative. The solution must not be utilized beyond the expiration date indicated on the packaging.
Packaging Description:
Chymotrypsin solution is presented in vial packaging containing 10 single-dose units. Each vial is clearly labeled with essential details including the product name, potency, and batch number for traceability purposes. Proper disposal of used vials should be carried out in accordance with local regulations.
